Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 05, 2026
TickeronGET DAILY SIGNALS
Anheuser-Busch InBev (BUD): Q1 2026 Earnings Beat Highlights Premiumization Strength

Anheuser-Busch InBev (BUD): Q1 2026 Earnings Beat Highlights Premiumization Strength

Key Takeaways

  • Anheuser-Busch InBev reported Q1 2026 revenue of $15.267 billion, up 5.8% organically from $13.628 billion in Q1 2025, beating consensus estimates around $14.7 billion.
  • Underlying EPS rose 20.8% to $0.97 from $0.81 year-over-year, surpassing analyst expectations of approximately $0.90-$0.91.
  • Beer volumes grew 1.2% organically, with record highs in key markets like Mexico and Brazil; total volumes up 0.8%.
  • Normalized EBITDA increased 5.3% to $5.437 billion, margin stable at 35.6%; megabrands like Corona up 8.2% in revenue.
  • Company reaffirmed FY 2026 EBITDA growth outlook of 4-8% in line with medium-term targets.

Q1 Earnings in Context: What Stands Out for BUD Investors

Anheuser-Busch InBev (BUD), the world's largest brewer, released its first quarter 2026 results on May 5, 2026. From what I see, these numbers offer valuable insights into global beer demand, especially as consumers shift toward premium and no-alcohol products. This report matters for investors because BUD continues to navigate U.S. market challenges stemming from prior brand issues, while leveraging megabrands like Corona and Stella Artois in emerging markets. Recent quarters have demonstrated resilience with consistent beats, though volume pressures in mature markets and currency volatility remain ongoing tests. The strong Q1 performance reinforces the company's execution on its premiumization strategy in a competitive landscape marked by inflation and regulatory hurdles.

Breaking Down the Reported Numbers

For Q1 2026 (January-March), Anheuser-Busch InBev (BUD) posted revenue of $15.267 billion, reflecting a 5.8% organic increase (12.0% reported) from $13.628 billion in Q1 2025. This topped consensus estimates of about $14.7 billion. Revenue per hectoliter (hl) rose 4.5%, propelled by megabrands (up 8.2%), no-alcohol beer (up 27%), and Beyond Beer (up 37%). Total volumes grew 0.8% to 136.4 million hl, with beer volumes up 1.2% to 118.5 million hl—beating expectations of a decline.

Normalized EBITDA climbed 5.3% to $5.437 billion from $4.855 billion, exceeding consensus growth of 2.6%, although the margin dipped 15 basis points to 35.6%. Underlying profit reached $1.923 billion, up from $1.606 billion. Underlying EPS surged 20.8% to a Q1 record $0.97 (8.8% constant currency) from $0.81, above forecasts near $0.91. Reported profit attributable to equity holders was $2.563 billion versus $2.148 billion.

I also checked this using Tickeron’s AI Screener to see how BUD stacks up against peers on key metrics like revenue growth and margins.

Discovering Opportunities with Tickeron’s AI Screener

In my own research, I rely on Tickeron’s AI Screener, an AI-powered tool for stock and ETF discovery. It lets me filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. With customizable options like industry, market cap, technical indicators, price patterns, and performance metrics, scanning thousands of assets becomes far more efficient than manual methods. This helps pinpoint trade ideas, trending stocks, breakout candidates, and hidden opportunities. I find it enhances my strategy—worth exploring if you're looking to streamline your screening process.

Initial Market Reaction and Sentiment

As of early trading on May 5, 2026, after the pre-market earnings release, BUD shares showed a mixed initial reaction amid broader market conditions. The stock had closed at $73.91 on May 4, down 2.18%, with pre-market indications varying. Investors seem positive on the earnings beat and volume growth, but cautious about margin pressure and non-beer volume declines. Sentiment centers on premium brand momentum offsetting U.S. softness, and analysts are likely to emphasize the reaffirmed outlook. I'm watching this closely as the day unfolds.

Looking Ahead: Guidance and Factors to Track

Anheuser-Busch InBev (BUD) reaffirmed its FY 2026 guidance, projecting normalized EBITDA growth of 4-8%, aligned with medium-term targets. In my view, this signals confidence in megabrand execution and category leadership despite headwinds. Key details include quarterly net finance costs of $190-220 million, average gross debt coupon around 4%, normalized effective tax rate of 26-28%, and net capital expenditure of $3.5-4.0 billion. The company has completed $1.4 billion of a $6 billion share buyback program as of May 1.

One thing that stands out is the need to monitor megabrands like Corona (up 16% outside home market) and innovations in no-alcohol and Beyond Beer for sustained revenue per hl growth. Beer volume trends in high-growth markets like Mexico and Brazil, versus declines in non-beer, will be critical. Upcoming catalysts include major sporting events like the Milano Cortina Winter Olympics activation and broader 2026 celebrations to boost demand.

Keep an eye on margin dynamics amid cost inflation, currency impacts (positive in Q1), and BEES platform expansion (GMV up 15% to $14.6 billion). Progress on debt reduction (net debt to EBITDA at 2.87x end-2025) and free cash flow generation remains essential for shareholder returns.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: BUD

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for BUD turns positive, indicating new upward trend

BUD saw its Momentum Indicator move above the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In 44 of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at 56%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 30 of 58 cases where BUD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 52%.

The Moving Average Convergence Divergence (MACD) for BUD just turned positive on November 02, 2026. Looking at past instances where BUD's MACD turned positive, the stock continued to rise in 23 of 44 cases over the following month. The odds of a continued upward trend are 52%.

BUD moved above its 50-day moving average on October 13, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BUD crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.

Following a +5.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where BUD advanced for three days, in 182 of 328 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.

The Aroon Indicator entered an Uptrend today. In 136 of 264 cases where BUD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.

Bearish Trend Analysis

The 10-day RSI Indicator for BUD moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 15 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 48%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BUD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

BUD broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 29 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. BUD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.768) is normal, around the industry mean (1.256). BUD has a moderately high P/E Ratio (17.753) as compared to the industry average of (0.039). Projected Growth (PEG Ratio) (1.583) is also within normal values, averaging (2.082). Dividend Yield (0.056) settles around the average of (0.039) among similar stocks. BUD's P/S Ratio (2.564) is slightly higher than the industry average of (1.539).

The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Anheuser-Busch INBEV SA/NV (NYSE:BUD), Constellation Brands (NYSE:STZ), Molson Coors Beverage Company (NYSE:TAP).

Industry description

The meat, fish, and dairy food industry processes livestock, fish and milk products for consumer consumption. Some companies also process dairy byproducts. Tyson Foods, Inc., Hormel Foods Corporation and Pilgrims Pride Corp. are some of the biggest producers in this industry. Many of these companies are recipients of American farm subsidies. On the other hand, new-age food innovation like plant-based meat substitutes (which are designed to simulate chicken, beef, and pork sausage) could potentially augur disruptions and/or create new competition in this space.

Market Cap

The average market capitalization across the Food: Meat/Fish/Dairy Industry is 39.55B. The market cap for tickers in the group ranges from 128.95K to 165.35B. BUD holds the highest valuation in this group at 165.35B. The lowest valued company is ENHD at 128.95K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Meat/Fish/Dairy Industry was 2%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was -3%. SAM experienced the highest price growth at 10%, while ABEV experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Food: Meat/Fish/Dairy Industry was -60%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 90
Price Growth Rating: 49
SMR Rating: 64
Profit Risk Rating: 71
Seasonality Score: 12 (-100 ... +100)
View a ticker or compare two or three
BUD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company whose subsidiaries manufactures and distributes alcoholic and non-alcoholic beverages

Industry FoodMeatFishDairy

Industry
Beverages Alcoholic
Address
Brouwerijplein 1
Phone
+32 16276888
Employees
143000
Web
https://www.ab-inbev.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of approximately $8.5 billion, a roughly 5% increase from $8.1 billion in Q1 2025. Consensus adjusted earnings per share (EPS) forecast stands at $4.74, reflecting a potential decline from prior-year levels amid pricing pressures.
Analysts expect Q1 2026 adjusted EPS of around $1.61, down from prior year levels due to softer commodity prices. Consensus revenue forecast stands at approximately $14.5 billion, reflecting a year-over-year decline.